AMED Amedisys Inc.

Amedisys Extends Employment Agreement with CEO Paul Kusserow

Amedisys Extends Employment Agreement with CEO Paul Kusserow

On Heels of Company Turnaround, Will Stay On For Three More Years

BATON ROUGE, La., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), America’s leading independent home health, hospice and personal care company, announced today that it has extended its employment agreement with Paul Kusserow, its president and CEO, from September 27, 2018 to December 16, 2021, adding three more years.

Kusserow joined the Company on December 11, 2014. In the nearly four years since then, he has led Amedisys in a dramatic turnaround clinically, culturally and financially. Under Kusserow’s leadership, Amedisys’ home health star ratings reached an industry-leading average of 4.38 stars; its stock has nearly quintupled, from $26 to an all-time high of $124 and its market cap has almost quadrupled, from $889 million to $3.84 billion.

“I’m excited to have the opportunity to continue the job we started less than four years ago,” Kusserow said. “Yet in many respects, I feel as if we’re only now getting going. Every organization needs a sense of stability and continuity to keep growing and striving for excellence. I look forward to working with this outstanding executive leadership team and our more than 19,000 employees to realize our strategy of becoming the solution for those who want to age in place. I consider it an honor and privilege to continue caring for seniors where they most want to be - in the home.”

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With 18,300 employees in 420 care centers in 34 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 369,000 patients and clients in need every year. For more information about the Company, please visit: .

Contact:

Kendra Kimmons

Vice President of Marketing & Communications

225-299-3708

 

EN
03/10/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amedisys Inc.

 PRESS RELEASE

Amedisys Reports Second Quarter 2025 Financial Results

Amedisys Reports Second Quarter 2025 Financial Results BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025. Three-Month Periods Ended June 30, 2025 and 2024 Net service revenue increased $30.7 million to $621.9 million compared to $591.2 million in 2024.Net income attributable to Amedisys, Inc. of $28.1 million, which is inclusive of merger-related expenses totaling $26.3 million ($26.1 million, net of tax), compared to net income attributable to Amedisys, ...

 PRESS RELEASE

Amedisys Reports First Quarter 2025 Financial Results

Amedisys Reports First Quarter 2025 Financial Results BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March 31, 2025 and 2024 Net service revenue increased $23.4 million to $594.8 million compared to $571.4 million in 2024.Net income attributable to Amedisys, Inc. of $61.0 million, which is inclusive of merger-related expenses totaling $16.8 million ($16.6 million, net of tax) and a $48.1 million gain on an equity method investment ($35.6 mi...

 PRESS RELEASE

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods Ended December 31, 2024 and 2023 Net service revenue increased $27.3 million to $598.1 million compared to $570.8 million in 2023.Net loss attributable to Amedisys, Inc. of $20.4 million, which is inclusive of merger-related expenses totaling $17.4 million ($15.9 million, net of tax) and a non-cash goodwill and other inta...

 PRESS RELEASE

Amedisys Honors 47 Employees With Annual Spirit of Excellence Award

Amedisys Honors 47 Employees With Annual Spirit of Excellence Award BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the prestigious Spirit of Excellence Awards, one of the company’s highest honors. “Every day, our employees bring warmth, compassion and clinical expertise into the homes of our patients, offering the care they need in the place they most want to be,” said Richard Ashworth, President and Chief Executive Officer. “We are privileged to ...

 PRESS RELEASE

Amedisys Reports Third Quarter 2024 Financial Results

Amedisys Reports Third Quarter 2024 Financial Results BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods Ended September 30, 2024 and 2023 Net service revenue increased $31.5 million to $587.7 million compared to $556.2 million in 2023.Net income attributable to Amedisys, Inc. of $16.9 million, which is inclusive of merger-related expenses totaling $16.7 million ($16.7 million, net of tax) compared to net income attributable...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch